GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Exagen Inc (NAS:XGN) » Definitions » Occupancy Rate %

Exagen (Exagen) Occupancy Rate % : 0.00% (As of Sep. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Exagen Occupancy Rate %?

Occupancy Rate % shows the actual utilization of an inpatient health facility for a given time period.

The historical rank and industry rank for Exagen's Occupancy Rate % or its related term are showing as below:

XGN's Occupancy Rate % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median:
* Ranked among companies with meaningful Occupancy Rate % only.

Exagen Occupancy Rate % Historical Data

The historical data trend for Exagen's Occupancy Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exagen Occupancy Rate % Chart

Exagen Annual Data
Trend Dec22 Dec23
Occupancy Rate %
Get a 7-Day Free Trial
Medicare Income Percentage of Revenue %
Get a 7-Day Free Trial

ExagenQuarterly Data
Trend Mar23 Jun23 Sep23
Occupancy Rate %
Get a 7-Day Free Trial
Medicare Income Percentage of Revenue %
Get a 7-Day Free Trial

Competitive Comparison of Exagen's Occupancy Rate %

For the Diagnostics & Research subindustry, Exagen's Occupancy Rate %, along with its competitors' market caps and Occupancy Rate % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Exagen  (NAS:XGN) Occupancy Rate % Calculation

To calculate Occupancy Rate %, we use inpatient days of care and bed days available. Inpatient days of care is the sum of each daily inpatient census for the year. Bed days available is the maximum number of inpatient days of care that would have been provided if all beds were filled during the year. The formula is:

Occupancy Rate %=( Inpatient Days of Care / Bed Days Available ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Exagen  (NAS:XGN) Occupancy Rate % Explanation

Occupancy Rate % is a calculation used to show the actual utilization of an inpatient health facility for a given time period. The occupancy rate reflects the degree to which hospital beds have been utilized even though the number of beds may have changed during the reporting period.

The average occupancy rate of community (that is, non-Federal, short-term general) hospitals is about 76%. We can recognize a hospital with a too-low occupancy rate as inefficient; such a hospital may find it hard to meet its profit goals. However, a constantly high occupancy rate may not be a good sign, either. Very high occupancy rates may reflect that the hospital is under great pressure from medical and labor sources. Thus, a reasonable occupancy rate is more acceptable than a high one.


Exagen Occupancy Rate % Related Terms

Thank you for viewing the detailed overview of Exagen's Occupancy Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.


Exagen (Exagen) Business Description

Traded in Other Exchanges
Address
1261 Liberty Way, Vista, CA, USA, 92081
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
Executives
John Aballi director, officer: President and CEO C/O DECIPHER BIOSCIENCES, INC., 6925 LUSK BLVD, SUITE 200, SAN DIEGO CA 92121
Paul Kim director 4399 SANTA ANITA AVE, EL MONTE CA 91731
Tullis Growth Fund Ii, L.p. 10 percent owner 11770 US HWY 1, STE 503, PALM BEACH GARDENS FL 33408
Kamal Adawi officer: Chief Financial Officer C/O EXAGEN INC., 1261 LIBERTY WAY, SUITE C, VISTA CA 92131
Mark Hazeltine officer: Chief Operating Officer C/O EXAGEN INC., 1261 LIBERTY WAY, SUITE C, VISTA CA 92081
Wendy S. Johnson director 800 E. LEIGH STREET, SUITE 209, RICHMOND VA 21219
Tullis James L L director, 10 percent owner 100 FIRST STAMFORD PLACE, STAMFORD CT 06907
Ana Hooker director 441 CHARMANY DRIVE, MADISON WI 53719
Frank Stokes director C/O CASTLE BIOSCIENCES, 820 S. FRIENDSWOOD DRIVE, SUITE 201, FRIENDSWOOD TX 77546
Hunt Holdings Limited Partnership 10 percent owner C/O EXAGEN INC., 1261 LIBERTY WAY, SUITE C, VISTA CA 92081
Nmsic Co-investment Fund, L.p. 10 percent owner C/O EXAGEN INC., 1261 LIBERTY WAY, SUITE C, VISTA CA 92081
Debra Zack officer: Chief Medical Officer C/O EXAGEN, INC., 1261 LIBERTY WAY, SUITE C, VISTA CA 92081
H.i.g. Bio-exagen, L.p. 10 percent owner C/O EXAGEN INC., 1261 LIBERTY WAY, SUITE C, VISTA CA 92081
Thierry Dervieux officer: Chief Scientific Officer C/O EXAGEN DIAGNOSTICS, INC., 1261 LIBERTY WAY, VISTA CA 92081
Nmsic Focused Llc 10 percent owner C/O EXAGEN INC., 1261 LIBERTY WAY, SUITE C, VISTA CA 92081